When someone asks whether NAD+ can be harmful, they're usually asking one of two things: are the everyday side effects a problem? or is there a deeper risk I should know about? Here's the honest answer to both. In human trials so far, oral NAD+ precursors like NMN and nicotinamide riboside (NR) have been generally well tolerated at the doses studied, and reported side effects have been mostly mild. The real caveat isn't a dramatic danger — it's that the trials have been short and small, so long-term safety simply isn't settled, and a few specific groups should be more careful.
A lot of the people who ask this question are women in their 40s, 50s, and 60s who are being careful for the first time about what they put in their bodies — reading labels, asking better questions, and rightly skeptical of anything that sounds too good. That instinct is exactly right. The goal here isn't to talk you into or out of NAD+; it's to give you the real picture so you can decide with your eyes open.
So, can NAD+ be harmful?
For most healthy adults, the evidence we have points to NAD+ precursor supplements being well tolerated — not dangerous — at typical doses. In a randomized, placebo-controlled trial, 1,250 mg of NMN taken once daily for four weeks produced no serious adverse events in healthy adults aged 20 to 65, including women. A separate 2 × 6-week controlled trial found that chronic NR supplementation was well tolerated and raised NAD+ levels in healthy middle-aged and older adults. That's reassuring. But "well tolerated for a few weeks in a few dozen people" is not the same as "proven safe for years," and it's worth being precise about that gap rather than papering over it.
If you're new to the category and want the basics first, our explainer on what NAD+ actually is → is a good starting point before you weigh the risks.
What side effects do people actually report?
When side effects show up in studies and real-world use, they tend to be mild, uncommon, and dose-related. The ones reported most often are:
- Nausea or stomach discomfort
- Loose stools or indigestion
- Headache
- Flushing or a warm sensation
- Fatigue
Most of these settle on their own or improve with a simple change. Taking the supplement with food, or starting at a lower dose and building up, is a reasonable first step. Symptoms that are severe, or that persist after you've adjusted, are a signal to stop and check with your clinician rather than push through.
What about the cancer question?
This is the worry that sends people down a late-night research hole, so let's be straight about it. The concern traces largely to a 2023 preclinical study: in a triple-negative breast cancer mouse model, NR supplementation increased cancer prevalence and the spread of tumors to the brain. The underlying idea is that cancer cells are metabolically hungry, and extra NAD+ raw material could, in some contexts, support that demand.
Two things matter here. First, this was an animal study using an aggressive, specific type of cancer — it has not been shown to happen in people, and it cannot be read as proof that supplements cause cancer in humans. Second, the researchers' own conclusion was about personalizing use, not banning it: anyone with an active cancer, a personal history of cancer, or a strong family risk should treat NAD+ supplements as a conversation to have with their oncologist or physician — not a default purchase. The right posture is honest caution, not alarm.
It's also worth keeping the scale of the evidence in view. The cancer concern rests on a single animal model of one aggressive tumor type; the human safety studies done so far weren't designed to detect a cancer signal one way or the other, and they haven't reported one. So the truthful summary is narrow: there's a preclinical flag worth respecting, no human confirmation, and a clear reason for some people to get individual advice before starting.
Does the dose — or the form — matter?
Yes, on both counts. Human trials have generally studied oral NMN in the range of a few hundred milligrams up to about 1,250 mg per day, and oral NR at similar-to-higher amounts, with good tolerability at those levels. More is not automatically better: pushing far beyond studied doses moves you into territory no trial has actually checked, which is the opposite of evidence-informed.
Form matters too. Intravenous NAD+ — the IV drips and injection protocols some clinics sell — is a different thing entirely from a daily capsule. Infusions can cause nausea, flushing, or chest tightness during the drip and belong under medical supervision. Don't equate a clinic IV with an oral supplement; the safety conversation around each is its own. If you're choosing between oral products, our guide to NAD+ supplements that actually work → covers dose, testing, and labels.
Who should be more cautious?
Most healthy adults don't need special clearance to take a sensible oral dose. But some people should talk to a clinician before starting:
- Anyone pregnant or breastfeeding
- Anyone with an active cancer or a history of cancer (see above)
- Anyone taking prescription medication
- Anyone scheduled for surgery
- People under 18
- Anyone managing a chronic health condition
This isn't fine print meant to scare you off — it's the same caution any responsible supplement should carry, and following it is part of using one well.
What we know — and what we still don't
What we know: across multiple human trials, oral NMN and NR have been well tolerated over weeks to a few months, with side effects that are usually mild. The short-term safety signal is genuinely encouraging.
What we don't: the trials are mostly small and short. A leading 2023 review of NAD+ in aging biology was titled, fittingly, "Potential Applications and Many Unknowns" — long-term safety, the ideal dose, and who benefits most are still open questions. Anyone who tells you the multi-year picture is settled is overselling it. Honesty about that uncertainty is exactly what you should expect from a brand worth trusting.
What NAD+ supplements won't do
- They won't reverse aging → or turn back your biological clock.
- They won't guarantee a particular result or feeling.
- They won't compensate for poor sleep, diet, or movement.
- They won't replace medical care or a prescription.
Where CELLSHE fits
We make NAD+ supplements, so take this as a company that would rather keep you than impress you: the honest move is to choose a transparent, third-party-tested product, use a sensible dose, and treat it as one part of a daily routine — not a shortcut. Our NMN 500 → supports cellular energy production* and offers a non-hormonal, science-grounded approach to healthy aging*, and our NAD+ → is formulated to support cellular function and healthy aging*. None of that overrides the guidance above — if anything on this page applies to you, talk to your clinician first.
Frequently asked questions
Is it safe to take NAD+ supplements every day?
In human trials, daily oral NMN and NR have been well tolerated for several weeks to a few months at the doses studied, with mostly mild side effects. Daily use at a sensible dose appears reasonable for healthy adults, but long-term safety hasn't been established, so periodic check-ins with your clinician are wise.
Can NAD+ supplements cause cancer?
There is no evidence in humans that NAD+ supplements cause cancer. The concern comes from a preclinical mouse study in which NR increased the spread of an aggressive breast cancer. It has not been shown in people, but anyone with a current or past cancer should check with their oncologist before using NAD+ supplements.
What are the most common NAD+ side effects?
When they occur, they are usually mild: nausea, stomach discomfort or loose stools, headache, flushing, or fatigue. Taking the supplement with food or lowering the dose often helps. Severe or lasting symptoms are a reason to stop and talk to a clinician.
Are there long-term risks from taking NMN or NR?
We don't fully know. Most human trials have lasted weeks to a few months, so the multi-year picture is genuinely unstudied. That uncertainty is the main honest caveat — not a known long-term danger.
Is NMN or NR safer?
Both have good short-term tolerability records in human trials, and there is no clear evidence that one is meaningfully safer than the other for healthy adults. Form matters less than dose, product quality, and third-party testing.
References
- Martens CR, et al. (2018). Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun. PMID: 29599478. pubmed.ncbi.nlm.nih.gov/29599478
- Fukamizu Y, et al. (2022). Safety evaluation of β-nicotinamide mononucleotide oral administration in healthy adult men and women. Sci Rep. PMID: 36002548. pubmed.ncbi.nlm.nih.gov/36002548
- Song Q, et al. (2023). The Safety and Antiaging Effects of Nicotinamide Mononucleotide in Human Clinical Trials: an Update. Adv Nutr. PMID: 37619764. pubmed.ncbi.nlm.nih.gov/37619764
- Maric T, et al. (2023). A bioluminescent-based probe for in vivo non-invasive monitoring of nicotinamide riboside uptake reveals a link between metastasis and NAD+ metabolism. Biosens Bioelectron. PMID: 36371959. pubmed.ncbi.nlm.nih.gov/36371959
- Bhasin S, et al. (2023). Nicotinamide Adenine Dinucleotide in Aging Biology: Potential Applications and Many Unknowns. Endocr Rev. PMID: 37364580. pubmed.ncbi.nlm.nih.gov/37364580
